Follow
J. Matthew Meinig
J. Matthew Meinig
USAMRIID
Verified email at health.mil
Title
Cited by
Cited by
Year
Synthesis of fluorophores that target small molecules to the endoplasmic reticulum of living mammalian cells
JM Meinig, L Fu, BR Peterson
Angewandte Chemie 127 (33), 9832-9835, 2015
672015
Sobetirome prodrug esters with enhanced blood–brain barrier permeability
AT Placzek, SJ Ferrara, MD Hartley, HS Sanford-Crane, JM Meinig, ...
Bioorganic & medicinal chemistry 24 (22), 5842-5854, 2016
402016
Ester-to-amide rearrangement of ethanolamine-derived prodrugs of sobetirome with increased blood-brain barrier penetration
SJ Ferrara, JM Meinig, AT Placzek, T Banerji, P McTigue, MD Hartley, ...
Bioorganic & medicinal chemistry 25 (10), 2743-2753, 2017
332017
Targeting fatty-acid amide hydrolase with prodrugs for CNS-selective therapy
JM Meinig, SJ Ferrara, T Banerji, T Banerji, HS Sanford-Crane, ...
ACS chemical neuroscience 8 (11), 2468-2476, 2017
322017
Anticancer/antiviral agent Akt inhibitor-IV massively accumulates in mitochondria and potently disrupts cellular bioenergetics
JM Meinig, BR Peterson
ACS chemical biology 10 (2), 570-576, 2014
122014
Structure-Activity Relationships of Central Nervous System Penetration by Fatty Acid Amide Hydrolase (FAAH)-Targeted Thyromimetic Prodrugs
JM Meinig, SJ Ferrara, T Banerji, T Banerji, HS Sanford-Crane, ...
ACS Medicinal Chemistry Letters 10 (1), 111-116, 2019
92019
Derivatives of sobetirome
TS Scanlan, A Placzek, T Banerji, S Ferrara, JM Meinig
US Patent 9,701,650, 2017
72017
Derivatives of sobetirome
TS Scanlan, A Placzek, T Banerji, S Ferrara, JM Meinig
US Patent App. 15/615,408, 2018
52018
The system can't perform the operation now. Try again later.
Articles 1–8